GlaxoSmithKline shares rally in weaker FTSE 100

Investors reassess the prospects for a U.S. generic launch of one of the pharmaceuticals key asthma drugs.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.